Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
By Puyaan Singh and Sahil Pandey Jan 29 (Reuters) - Thermo Fisher Scientific on Thursday forecast annual profit below Wall ...
Thermo Fisher Scientific on Thursday beat Wall Street estimates for fourth-quarter profit and revenue on strong demand for ...
Zacks Investment Research on MSN
Thermo Fisher's Q4 earnings & revenues top estimates, stock climbs
Thermo Fisher Scientific Inc.'s TMO fourth-quarter 2025 adjusted earnings per share (EPS) of $6.57 beat the Zacks Consensus ...
Thusday morning, Thermo Fisher Scientific, which has a laboratory in Center Valley and also an Allentown location, reported ...
Thermo Fisher beat Q4 earnings and revenue estimates, driven by life sciences growth, and forecast 4%–6% revenue growth with ...
Thermo Fisher Scientific has received a total of 8 ratings from analysts, with the consensus rating as Buy. With an average ...
Thermo Fisher and NVIDIA collaborate to integrate AI into scientific research, enhancing laboratory automation and efficiency. Thermo Fisher Scientific has entered a strategic collaboration with ...
Thermo Fisher Scientific: recent gains put performance in focus Thermo Fisher Scientific (TMO) has drawn investor attention ...
The large laboratory equipment supplier had grown its Western North Carolina site during the pandemic.
Q4 2025 Earnings Call January 29, 2026 8:30 AM EST Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2025 Fourth Quarter Conference Call. [Operator Instructions] I would ...
The DXR3 SmartRaman+ Spectrometeris an at-line Raman spectrometer designed for pharmaceutical quality control.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results